Darryl C Baptiste1, Michael G Fehlings. 1. Toronto Western Hospital, Division of Cellular & Molecular Biology, Toronto Western Research Institute and Krembil Neuroscience Centre, 12th Floor Room 407 McLaughlin Pavilion, 399 Bathurst Street, Toronto, Ontario, M5T 2S8, Canada.
Abstract
BACKGROUND: This review summarizes several promising pharmacological approaches for the therapeutic management of traumatic spinal cord injury (SCI), which are either in early-phase clinical trials or nearing clinical translation. OBJECTIVE: This review provides the reader with an understanding of the key pathophysiological mechanisms that contribute to neurological deficits after SCI. Through discussion of the mechanism(s) of action of the selected therapeutic approaches potentially important targets to aid further drug discovery will be highlighted. METHODS: Systematic literature review of the pre-clinical literature and clinical SCI trials related to neuroprotective, immunomodulatory and regenerative therapeutic approaches. RESULTS/ CONCLUSION: The next decade will witness an unprecedented number of clinical trials which will seek to translate key biomedical research discoveries. The promising drug-based therapeutic approaches include regenerative strategies to neutralize myelin-mediated neurite outgrowth inhibition, neuroprotective strategies to reduce apoptotic triggers, the targeting of cationic/glutamatergic toxicity, anti-inflammatory strategies and the use of approaches to stabilize disrupted cell membranes.
BACKGROUND: This review summarizes several promising pharmacological approaches for the therapeutic management of traumatic spinal cord injury (SCI), which are either in early-phase clinical trials or nearing clinical translation. OBJECTIVE: This review provides the reader with an understanding of the key pathophysiological mechanisms that contribute to neurological deficits after SCI. Through discussion of the mechanism(s) of action of the selected therapeutic approaches potentially important targets to aid further drug discovery will be highlighted. METHODS: Systematic literature review of the pre-clinical literature and clinical SCI trials related to neuroprotective, immunomodulatory and regenerative therapeutic approaches. RESULTS/ CONCLUSION: The next decade will witness an unprecedented number of clinical trials which will seek to translate key biomedical research discoveries. The promising drug-based therapeutic approaches include regenerative strategies to neutralize myelin-mediated neurite outgrowth inhibition, neuroprotective strategies to reduce apoptotic triggers, the targeting of cationic/glutamatergic toxicity, anti-inflammatory strategies and the use of approaches to stabilize disrupted cell membranes.
Authors: Hasan Kara; Selim Degirmenci; Ahmet Ak; Aysegul Bayir; Seyit Ali Kayis; Mehmet Uyar; Murat Akinci; Demet Acar; Metin Kocacan; Fikret Akyurek Journal: Bosn J Basic Med Sci Date: 2015-01-08 Impact factor: 3.363
Authors: Timothy L Downing; Aijun Wang; Zhi-Qiang Yan; Yvette Nout; Andy L Lee; Michael S Beattie; Jacqueline C Bresnahan; Diana L Farmer; Song Li Journal: J Control Release Date: 2012-05-23 Impact factor: 9.776
Authors: Yiqian Zhu; Aijun Wang; Wenqian Shen; Shyam Patel; Rong Zhang; William Young; Song Li Journal: Adv Funct Mater Date: 2010-03-17 Impact factor: 18.808